Cramer-van der Welle C - Search Results

1

Incentivizing appropriate prescribing in primary care: Development and first results of an electronic health record-based pay-for-performance scheme.

Ramerman L, Hek K, Cramer-van der Welle C, Simons-Winters E, Middelweerd A, Lambooij A, Verheij R. Ramerman L, et al. Among authors: cramer van der welle c. Health Policy. 2022 Oct;126(10):1010-1017. doi: 10.1016/j.healthpol.2022.07.004. Epub 2022 Jul 17. Health Policy. 2022. PMID: 35870964 Free article.

2

'Care for Outcomes': systematic development of a set of outcome indicators to improve patient-relevant outcomes for patients with lung cancer.

Cramer-van der Welle CM, van Loenhout L, van den Borne BE, Schramel FM, Dijksman LM. Cramer-van der Welle CM, et al. BMJ Open. 2021 Jan 15;11(1):e043229. doi: 10.1136/bmjopen-2020-043229. BMJ Open. 2021. PMID: 33452199 Free PMC article.

3

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.

Cramer-van der Welle CM, Schramel FMNH, Peters BJM, van Putten JWG, Klungel OH, Groen HJM, van de Garde EMW; Santeon SCLC Study Group. Cramer-van der Welle CM, et al. Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):445-450. doi: 10.1002/pds.5179. Epub 2020 Dec 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33295644

4

Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer.

Cramer-van der Welle CM, Peters BJM, Schramel FMNH, Klungel OH, Groen HJM, van de Garde EMW; Santeon NSCLC Study Group; Santeon NSCLC study group. Cramer-van der Welle CM, et al. Eur Respir J. 2018 Dec 20;52(6):1801100. doi: 10.1183/13993003.01100-2018. Print 2018 Dec. Eur Respir J. 2018. PMID: 30487206 Free PMC article.

5

Real-world treatment patterns and outcomes of patients with extensive disease small cell lung cancer.

Cramer-van der Welle CM, Schramel FMNH, van Leeuwen AS, Groen HJM, van de Garde EMW; Santeon SCLC Study Group. Cramer-van der Welle CM, et al. Eur J Cancer Care (Engl). 2020 Sep;29(5):e13250. doi: 10.1111/ecc.13250. Epub 2020 May 14. Eur J Cancer Care (Engl). 2020. PMID: 32406593 Free PMC article.

6

Trends in Drug Costs and Overall Survival in Patients with Metastatic Non-small Cell Lung Cancer in The Netherlands Diagnosed from 2008 Through 2014.

Cramer-van der Welle CM, Peters BJM, Deenen MJ, Schramel FMNH, van de Garde EMW. Cramer-van der Welle CM, et al. Pharmacoecon Open. 2021 Mar;5(1):121-127. doi: 10.1007/s41669-020-00220-z. Pharmacoecon Open. 2021. PMID: 32533521 Free PMC article.

7

Development and Evaluation of a Real-World Outcomes-Based Tool to Support Informed Clinical Decision Making in the Palliative Treatment of Patients With Metastatic NSCLC.

Cramer-van der Welle CM, Kastelijn EA, Plouvier BC, van Uden-Kraan CF, Schramel FMNH, Groen HJM, van de Garde EMW. Cramer-van der Welle CM, et al. JCO Clin Cancer Inform. 2021 May;5:570-578. doi: 10.1200/CCI.20.00160. JCO Clin Cancer Inform. 2021. PMID: 34010031 Free article.

8

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands.

Cramer-van der Welle CM, Verschueren MV, Tonn M, Peters BJM, Schramel FMNH, Klungel OH, Groen HJM, van de Garde EMW; Santeon NSCLC Study Group. Cramer-van der Welle CM, et al. Sci Rep. 2021 Mar 18;11(1):6306. doi: 10.1038/s41598-021-85696-3. Sci Rep. 2021. PMID: 33737641 Free PMC article.

9

Communication about Drug-Related Problems (DRPs) during Patients' Visits to Dutch Physicians and Pharmacies.

Huiskes VJB, Cramer-van der Welle CM, van den Ende CHM, van Dijk L, Bos JM, Kramers C, van den Bemt BJF. Huiskes VJB, et al. Among authors: cramer van der welle cm. Health Commun. 2020 Feb;35(2):201-208. doi: 10.1080/10410236.2018.1551301. Epub 2018 Dec 10. Health Commun. 2020. PMID: 30526088

10

Individual patient data to allow a more elaborated comparison of trial results with real-world outcomes from first-line immunotherapy in NSCLC.

Ismail RK, Schramel FMNH, van Dartel M, Pasmooij AMG, Cramer-van der Welle CM, Hilarius DL, de Boer A, Wouters MWJM, van de Garde EMW. Ismail RK, et al. Among authors: cramer van der welle cm. BMC Med Res Methodol. 2023 Jan 3;23(1):1. doi: 10.1186/s12874-022-01760-0. BMC Med Res Methodol. 2023. PMID: 36593440 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page